SIC
LAB icon

SJS Investment Consulting’s Standard BioTools LAB Stock Holding History

SJS Investment Consulting’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144 Buy
174
+118
+211% +$111 ﹤0.01% 2533
2026
Q1 		$52 Buy
+56
New +$68 ﹤0.01% 2246

Other funds holding LAB

PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
EWA
Evolution Wealth Advisors Aventura, Florida $855M AUM 27.24% 1-Year Est. Return
VWA
VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SJS Investment Consulting's LAB Position: Q2 2026 in Review

SJS Investment Consulting increased its Standard BioTools (LAB) stake by 211% in Q2 2026, buying an estimated $111 and bringing the position to 174 shares worth $144. The position accounts for ﹤0.01% of the portfolio, ranked #2533.

SJS Investment Consulting first reported a position in LAB in Q1 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • SJS Investment Consulting held 174 shares of Standard BioTools worth $144 as of Q2 2026.
  • SJS Investment Consulting bought 118 Standard BioTools shares in Q2 2026, an estimated $111.
  • Standard BioTools made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2533 holding.
  • SJS Investment Consulting first reported a position in Standard BioTools in Q1 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.